BRD4-targeting PROTAC as a unique tool to study biomolecular condensates
Yi Shi(Center for Life Sciences), Yu Rao(Soochow University), Qianlong Liu(Center for Life Sciences), Minglei Shi(Peking University), Pilong Li(Center for Life Sciences), Zhenzhen Zhang(Zhejiang Normal University), Haitao Li(King Center), Yuan Liao(Peking University), Zhihao Ni(Tsinghua University)
Cited by 56
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270